UF study questions accuracy of CMS opioid safeguards
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
Posts tagged as
Almutwinterstein
Center for Drug Evaluation and Safety established at the University of Florida
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
UF study to examine the safety of contrast agents used in MRI body scans during pregnancy
The FDA awarded a $330,000 grant to Almut Winterstein, Ph.D., to lead the 18-month study.
Novel risk score to prevent adverse drug events wins ASHP Pharmacy Practice Research Award
The 2018 Pharmacy Practice Research Award was presented at the ASHP Midyear meeting in Anaheim.
Dr. Winterstein installed as president-elect of the International Society for Pharmacoepidemiology
As president-elect, Almut Winterstein will serve on the executive board and chair the strategic planning committee. She joined ISPE in 2000 and has held numerous leadership roles during the past two decades.
Study finds that short-term use of azithromycin is not associated with increased risk of hearing loss
The researchers reviewed medical claims for around half million adults in 29 states who had used either azithromycin or amoxicillin during a 10 year period.
Drs. Wei and Winterstein publish ADHD study on JAMA Network Open
The study examines the prevalence and factors associated with the long-term concurrent use of stimulants and opioids among adults with ADHD.
Dr. Almut Winterstein named UF Term Professor
Winterstein is one of four UF College of Pharmacy faculty members named as UF Term Professors.
UF and Harvard researchers secure FDA grant to assess medication safety during pregnancy
The nearly $3 million grant will enhance the FDA’s capability to conduct drug safety studies on maternal and infant outcomes involving exposure to medications during pregnancy.
Quinolone ear drops study wins Best Clinical Research Paper Award
The paper authored by researchers in the department of pharmaceutical outcomes and policy won the University of Florida College of Pharmacy’s 2018 Best Clinical Research Paper Award.
